Straumann analyst consensus stays robust, shares tracked on SIX and Xetra

Straumann enters midweek with a solid analyst consensus and clear sector positioning in dental implants, while its shares remain actively traded on the SIX Swiss Exchange and via German platforms such as Xetra and Tradegate.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-24, 10:21.

Straumann Holding AG (CH0012280076) starts midweek with a stable analyst picture and continued demand for its dental-implant focused shares on the SIX Swiss Exchange in Zurich. Consensus data from several platforms point to a predominantly positive stance on the stock, while sector peers such as Dentsply Sirona and Align Technology underline the competitive landscape in global oral care.

What analysts say today

Analyst summaries compiled by platforms such as MarketScreener indicate that a clear majority of covering houses rate the Straumann stock as Buy or equivalent, with only a minority assigning Hold or Sell recommendations, underlining a generally constructive stance on the group’s earnings trajectory. Analyst consensus overview on MarketScreener

Price-target distributions on the same platform cluster noticeably above recent trading ranges, suggesting that research houses including UBS, Vontobel and Deutsche Bank expect Straumann to defend or extend its profitability in premium dental implants and clear aligners in the coming years. Finanzen.net analyst compilation for Straumann

Position in the dental sector

Straumann competes globally with firms such as US-based Dentsply Sirona and Align Technology, both listed on NASDAQ and closely watched as benchmarks for dental equipment and orthodontics growth. The company’s focus on premium implants and digital workflows positions it in higher-margin segments of the oral care market. Reuters company profile for Straumann

Sector commentary from Reuters highlights stable structural demand drivers, including aging populations and higher aesthetic dentistry spending, although cyclical pressure from discretionary treatments and regional reimbursement changes remains a factor across the peer group. Bloomberg snapshot of Straumann and peers

The products behind Straumann

Straumann generates most of its revenue from premium dental implant systems and related prosthetic components under the Straumann and Neodent brands, complemented by clear aligner solutions marketed under the ClearCorrect name and a growing portfolio in digital dentistry and biomaterials.

Where the shares trade currently

The Straumann Holding AG shares (CH0012280076) trade on the SIX Swiss Exchange in Zurich as the primary listing; indicative reference prices from recent sessions place the stock in the low three-digit Swiss-franc range.

Key data on the Straumann shares

• Company: Straumann Holding AG
• ISIN: CH0012280076
• WKN: 914326
• Ticker: STMN
• Trading venue: SIX Swiss Exchange
• Price (as of 2026-06-24, 10:15): 130.00 CHF
• Market cap: 20.0 billion CHF (as of 2026-06-24)
• Sector / industry: Health Care / Medical Equipment, Dental
• Index membership: SMI Mid / SPI
• Next earnings date: 2026-08-16

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.